EWTX - Edgewise Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.00
DETAILS
HIGH:
$52.00
LOW:
$25.00
MEDIAN:
$45.50
CONSENSUS:
$42.00
UPSIDE:
28.44%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-05 | Donovan Joanne M. | officer: CMO | SELL | 50,000 | $38.57 | $1.9M |
| 2026-05-04 | Donovan Joanne M. | officer: CMO | SELL | 5,230 | $31.29 | $164K |
| 2026-05-05 | Donovan Joanne M. | officer: CMO | M-Exempt | 50,000 | $7.08 | $354K |
| 2026-04-01 | Fox Jonathan C | director | A-Award | 339 | -- | -- |
| 2026-04-01 | Donovan Joanne M. | officer: CMO | M-Exempt | 28,662 | $7.08 | $203K |
| 2026-04-01 | Donovan Joanne M. | officer: CMO | SELL | 28,662 | $32.31 | $926K |
| 2026-03-31 | Donovan Joanne M. | officer: CMO | M-Exempt | 21,338 | $7.08 | $151K |
| 2026-03-31 | Donovan Joanne M. | officer: CMO | SELL | 21,338 | $32.12 | $685K |
| 2026-03-27 | Donovan Joanne M. | officer: CMO | SELL | 9,623 | $30.98 | $298K |
| 2026-03-27 | Donovan Joanne M. | officer: CMO | SELL | 6,735 | $30.98 | $209K |
| 2026-01-21 | Edris Badreddin | director | M-Exempt | 17,236 | $0.64 | $11K |
| 2026-01-21 | Edris Badreddin | director | SELL | 10,463 | $29.44 | $308K |
| 2026-01-21 | Edris Badreddin | director | SELL | 13,690 | $29.44 | $403K |
| 2026-01-21 | Edris Badreddin | director | SELL | 17,236 | $29.44 | $507K |
| 2026-01-21 | Edris Badreddin | director | M-Exempt | 10,463 | $1.93 | $20K |
| 2026-01-21 | Edris Badreddin | director | SELL | 66,477 | $29.44 | $2.0M |
| 2026-01-21 | Edris Badreddin | director | M-Exempt | 7,605 | $0.71 | $5K |
| 2026-01-21 | Edris Badreddin | director | SELL | 7,605 | $29.44 | $224K |
| 2026-01-21 | Edris Badreddin | director | M-Exempt | 66,477 | $1.93 | $128K |
| 2026-01-21 | Edris Badreddin | director | M-Exempt | 13,690 | $0.39 | $5K |
| 2026-01-02 | Fox Jonathan C | director | A-Award | 473 | -- | -- |
| 2025-11-19 | Martin Christopher Nathan | director | A-Award | 45,150 | $22.34 | $1.0M |
| 2025-11-19 | Martin Christopher Nathan | ? | -- | -- | -- | |
| 2025-11-12 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | 100,000 | $0.18 | $18K |
| 2025-11-12 | Russell Alan J | director, officer: Chief Scientific Officer | SELL | 100,000 | $21.12 | $2.1M |